Ernexa Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Ernexa Therapeutics Inc. has filed 1,510 SEC EDGAR filings since 14 Feb 1994

SEC filing history

Showing 76-100 of 1,000 matching filings.

Per page
25
Current page
4
10-K File 001-11460

10-K filing

Filing date
12 Mar 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
SCHEDULE 13D/A File 005-42217

SCHEDULE 13D/A filing

Filing date
05 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-42217

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-42217

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-42217

SCHEDULE 13G/A filing

Filing date
12 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Feb 2025
Reporting date
07 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Feb 2025
Reporting date
07 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Feb 2025
Reporting date
07 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Feb 2025
Reporting date
07 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Feb 2025
Reporting date
07 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-42217

SCHEDULE 13G/A filing

Filing date
28 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Jan 2025
Reporting date
13 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
14 Jan 2025
Reporting date
07 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-276493

424B3 filing

Filing date
18 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-273977

424B3 filing

Filing date
18 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-283003

424B3 filing

Filing date
18 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-283003

EFFECT filing

Filing date
15 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-529371

D filing

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-529370

D filing

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .